HQL vs. THQ
HQL (Tekla Life Sciences Investors) is a stock, while THQ (Abrdn Healthcare Opportunities Fund) is Health & Biotech Equities fund managed by Aberdeen. Over the past 10 years, HQL returned 9.04%/yr vs 9.19%/yr for THQ. A 0.66 correlation means they provide meaningful diversification when combined.
Performance
HQL vs. THQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HQL achieves a 7.66% return, which is significantly higher than THQ's -2.61% return. Both investments have delivered pretty close results over the past 10 years, with HQL having a 9.04% annualized return and THQ not far ahead at 9.19%.
HQL
- 1D
- -1.46%
- 1M
- -1.33%
- YTD
- 7.66%
- 6M
- 5.52%
- 1Y
- 52.68%
- 3Y*
- 21.87%
- 5Y*
- 8.03%
- 10Y*
- 9.04%
THQ
- 1D
- -0.17%
- 1M
- -1.63%
- YTD
- -2.61%
- 6M
- -0.02%
- 1Y
- 9.03%
- 3Y*
- 9.04%
- 5Y*
- 3.43%
- 10Y*
- 9.19%
HQL vs. THQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HQL Tekla Life Sciences Investors | 7.66% | 45.48% | 11.03% | 4.23% | -19.21% | 5.52% | 23.72% | 25.53% | -16.18% | 25.41% |
THQ Abrdn Healthcare Opportunities Fund | -2.61% | 13.88% | 15.51% | -1.62% | -17.53% | 33.39% | 15.20% | 22.70% | 3.41% | 21.84% |
Correlation
The correlation between HQL and THQ is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.53 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.65 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2014 | 0.66 |
The correlation between HQL and THQ shifts across timeframes, from 0.53 (1 year) to 0.67 (10 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HQL vs. THQ — Risk / Return Rank
HQL
THQ
HQL vs. THQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and Abrdn Healthcare Opportunities Fund (THQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HQL | THQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.03 | ||
| Sortino ratioReturn per unit of downside risk | +2.55 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.10 | +0.32 |
| Calmar ratioReturn relative to maximum drawdown | 5.16 | 0.53 | +4.64 |
| Martin ratioReturn relative to average drawdown | 17.13 | 1.44 | +15.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HQL | THQ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.53 | 0.50 | +2.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.39 | 0.18 | +0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.41 | 0.45 | -0.04 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.36 | -0.05 |
Drawdowns
HQL vs. THQ - Drawdown Comparison
The maximum HQL drawdown since its inception was -62.65%, which is greater than THQ's maximum drawdown of -39.35%. Use the drawdown chart below to compare losses from any high point for HQL and THQ.
Loading charts...
Drawdown Indicators
| HQL | THQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.65% | -39.35% | -23.30% |
Max Drawdown (1Y)Largest decline over 1 year | -10.25% | -17.25% | +7.00% |
Max Drawdown (3Y)Largest decline over 3 years | -25.10% | -25.86% | +0.76% |
Max Drawdown (5Y)Largest decline over 5 years | -38.86% | -32.20% | -6.66% |
Max Drawdown (10Y)Largest decline over 10 years | -38.86% | -39.35% | +0.49% |
Current DrawdownCurrent decline from peak | -5.21% | -7.82% | +2.61% |
Average DrawdownAverage peak-to-trough decline | -22.27% | -8.63% | -13.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.08% | 6.29% | -3.21% |
Volatility
HQL vs. THQ - Volatility Comparison
Tekla Life Sciences Investors (HQL) has a higher volatility of 5.88% compared to Abrdn Healthcare Opportunities Fund (THQ) at 5.15%. This indicates that HQL's price experiences larger fluctuations and is considered to be riskier than THQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HQL | THQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.88% | 5.15% | +0.73% |
Volatility (6M)Calculated over the trailing 6-month period | 14.11% | 12.84% | +1.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.05% | 18.24% | +2.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.61% | 19.03% | +1.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.25% | 20.47% | +1.78% |
Dividends
HQL vs. THQ - Dividend Comparison
HQL's dividend yield for the trailing twelve months is around 12.05%, which matches THQ's 12.17% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HQL Tekla Life Sciences Investors | 12.05% | 10.85% | 14.18% | 9.44% | 9.57% | 8.79% | 7.90% | 8.03% | 10.72% | 8.25% | 12.18% | 11.84% |
THQ Abrdn Healthcare Opportunities Fund | 12.17% | 11.29% | 11.09% | 7.45% | 6.81% | 5.27% | 6.62% | 7.08% | 8.05% | 7.71% | 8.70% | 9.50% |
Frequently Asked Questions
HQL and THQ have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HQL has higher volatility (5.88%) compared to THQ (5.15%). In terms of maximum drawdown, HQL dropped -62.65% vs THQ's -39.35%.
HQL currently has the higher Sharpe Ratio (2.53 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HQL and THQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer